Human Serum Low Molecular Mass Prostate-Specific Antigen as Biomarker

• Published in: Journal of medical biochemistry Vol. 36; no. 4; pp. 322 - 330
• Main Authors: Goč, Sanja, Janković, Miroslava
• Format: Journal Article
• Language: English
• Published: Serbia De Gruyter Open 28.08.2017; Society of Medical Biochemists of Serbia; Sciendo; Society of Medical Biochemists of Serbia, Belgrade
• Subjects: Antigens; benign prostatic hyperplasia; Biodiversity; Biomarkers; Breast cancer; Glycoproteins; Hyperplasia; low molecular mass species; Mass spectrometry; Mass spectroscopy; Original Paper; Prostate cancer; Prostate-specific antigen; Rare species; Tumor markers; Urine; breast cancer; prostate cancer; benign prostatic hyperplasia; low molecular mass species; prostate-specific antigen
• ISSN: 1452-8266; 1452-8258; 1452-8266
• DOI: 10.1515/jomb-2017-0024

Background: Prostate-specific antigen (PSA) is a glycoprotein tumor marker known to exist as numerous glycospecies. Investigations on its glycobiochemical properties aimed at their use in the preparation of adjuncts in determining PSA concentration for clinical purposes have accumulated a lot of data on its structural properties. In this study, we reconsidered unexplored ubiquitously present low molecular mass species of PSA regarding to molecular mass, origin and pathophysiological source specificity in order to evaluate them as biomarkers. Methods: Data on low molecular mass PSA-immunoreactive species from sera of subjects with prostate cancer (PCa), benign prostatic hyperplasia (BPH), breast cancer (BCa), and urine of healthy males obtained by on-chip immunoaffinity chromatography combined with mass spectrometry were analyzed. Results: The results obtained indicated PSA species common to BCa, PCa, and BPH at 12-13 kDa, 17-19 kDa and 21-24 kDa. The striking difference in predominant frequencies made the profile characteristic in each examined pathophysiological condition. On the other hand, paired groups of prostatic and extraprostatic PSA contained rare species with small differences among groups concerning individual species. Low molecular mass PSA also included rare species unique for each group of samples. Conclusion: The results obtained revealed that uniformity of low molecular mass PSA-immunoreactive species in sera prevails over diversity related to cancer and non-cancer conditions, but at the same time some of them are molecules with biomarker potential for BPH detection.